Literature DB >> 31669814

Stigma Associated with Opioid Use Disorders in Adolescents Limits Naloxone Prescribing.

Lydia Carson1.   

Abstract

THEORETICAL PRINCIPLES: Parse's theory of humanbecoming describes shame as a sense that one is failing to conform to both personal and societal expectations of high value. Shame and stigma, negative perceptions others hold of an individual based on failure to conform to societal expectations, that surround opioid use disorders are linked to patients not seeking medical treatment due to the social isolation and humiliation brought on by the disease. PHENOMENON ADDRESSED: This article reviews the resistance of some health care providers to discuss the realities of substance abuse with adolescent patients and their families, and identifies how the stigma that some health care providers place on opioid use disorders makes them less likely to discuss and prescribe naloxone, the reversal agent for opioids. When families are prepared to prevent overdose deaths by administering naloxone, lives can be saved, and time can be preserved for developing long-term treatment options. RESEARCH LINKAGES: Research should develop curricula that teach how to identify unconscious bias that may exist on the part of the healthcare provider, and to understand the negative effects of stigmatizing opioid use. Bedside nurses and practitioners should be equipped to educate patients and their families about naloxone and its availability, and to explain that it is a safe and effective way to prevent opioid related deaths. When presented in a nonjudgmental way, information about naloxone is a critical component in addressing the opioid epidemic, preventing deaths and providing time for further treatment options.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Naloxone; Opioid use disorder; Stigma

Mesh:

Substances:

Year:  2019        PMID: 31669814     DOI: 10.1016/j.pedn.2019.10.005

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  4 in total

1.  Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.

Authors:  Robin A Pollini; Susannah Slocum; Jenny Ozga; Rebecca Joyce; Ziming Xuan; Traci C Green; Alexander Y Walley
Journal:  J Am Pharm Assoc (2003)       Date:  2021-08-23

2.  Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.

Authors:  Kelly Quinn; Sagar Kumar; Calli T Hunter; Julie O'Donnell; Nicole L Davis
Journal:  Drug Alcohol Depend       Date:  2022-04-16       Impact factor: 4.852

3.  Nobody Wants to Be Narcan'd: A Pilot Qualitative Analysis of Drug Users' Perspectives on Naloxone.

Authors:  Jeffrey T Lai; Charlotte E Goldfine; Brittany P Chapman; Melissa M Taylor; Rochelle K Rosen; Stephanie P Carreiro; Kavita M Babu
Journal:  West J Emerg Med       Date:  2021-02-08

4.  "People Don't Just Start Shooting Heroin on Their 18th Birthday": A Qualitative Study of Community Stakeholders' Perspectives on Adolescent Opioid Use and Opportunities for Intervention in Baltimore, Maryland.

Authors:  Sabriya L Linton; Abigail Winiker; Kayla N Tormohlen; Kristin E Schneider; Grace McLain; Susan G Sherman; Renee M Johnson
Journal:  Prev Sci       Date:  2021-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.